BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $29.76, but opened at $30.49. BridgeBio Pharma shares last traded at $30.08, with a volume of 180,372 shares traded. Wall Street Analyst Weigh In Several brokerages have issued reports on BBIO. […]
Raymond James initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a research note issued to investors on Thursday, StockNewsAPI reports. The firm issued an outperform rating and a $45.00 price target on the stock. Other analysts have also recently issued reports about the stock. Citigroup lifted their price objective on shares […]
JPMorgan Chase & Co. Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $45.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rhumbline Advisers grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 179,759 shares of the company’s stock after acquiring an additional 1,924 shares during the period. […]
313,381 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Purchased by Boone Capital Management LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.